Search
for
Sort by
Research 181–210 of 1000+
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- Under Development JAK Inhibitors for Dermatologic Diseases
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- BH03: Systemic sclerosis and frontal fibrosing alopecia: a novel combination of scarring alopecia
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- JAK inhibitors in dermatology: The promise of a new drug class
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Theoretical investigation on the construction of hair follicle membranes and the transdermal drug delivery mechanisms of JAK inhibitors via distinct pathways
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Age-associated inflammation inhibits epidermal stem cell function
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata
- TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- The role of janus kinases in the treatment of autoimmune skin diseases